The pharma and medical devices industry have many common challenges and opportunities. Over thirty years both industries, together with regulators, have been looking to simplify, standardize to assure quality of products for the benefit of patients. The presentation will draw upon the similarities and differences observed between the Pharma and Medical device industry and describe potential opportunities to leverage learning from both industries as they move towards more Global Regulatory coherence. The focus will be on how data can be viewed as an asset, which may open up opportunities for automation and productivity gains, and the need for more integrated E-2-E solutions. Solutions which have ‘Data Governance’ and ‘Data Exploitation’ enabled within the design.